John H. Sampson
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
John Howard Sampson is an American neurosurgeon who was formerly chief of the department of neurosurgery at Duke University where he serves as a professor of surgery, biomedical engineering, immunology, and pathology.[1]
Education[edit]
| This section of a biography of a living person does not include any references or sources. (November 2023) |
- B.Sc., University of Manitoba 1986
- MD, University of Manitoba Faculty of Medicine, 1990
- PhD, Neuro-Oncology, Duke University Medical Center, 1994-1996
- Residency: Neurosurgery, Duke University Medical Center, 1991-1998
- Fellowship: Neurological Intensive Care, Duke University Medical Center, 1998
- MHSc, Duke University, 2007
- MBA, Duke University Fuqua School of Business, 2011
Work and research[edit]
Sampson has written a variety of papers, including a paper in Nature on his clinical trial on the treatment of glioblastoma patients and another in how tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Clinical interests[edit]
Newly diagnosed or recurrent primary or metastic brain tumors, including enrollment in clinical trials of new therapeutic agents (especially oncolytic poliovirus therapy, immunotherapy, vaccines and convection-enhanced delivery); posterior fossa tumors, such as acoustic neuromas or meningiomas; microsurgery for tic douloureux or trigeminal neuralgia, including microvascular decompression; microvascular decompression for hemifacial spasm, pituitary tumors, complex skull-base tumors; radiosurgery; evaluation and surgery for patients with the full spectrum of other neurosurgery pathologies.
Media[edit]
Sampson has appeared on 60 Minutes and many other news networks for his work with glioblastoma cancer treatments.
References[edit]
- ^ "John H. Sampson | Duke Department of Neurosurgery". neurosurgery.duke.edu. Retrieved 2023-04-03.